InfoComm Asia 2023 Closes on a High
The expanded Professional AudioVisual and Transformative Technology Solutions tradeshow attracted 7,298 business visitors and hosted…
The expanded Professional AudioVisual and Transformative Technology Solutions tradeshow attracted 7,298 business visitors and hosted…
Home Showcase lets customers shop by room CITY OF INDUSTRY, Calif.–(BUSINESS WIRE)–$NEGG #ai–Newegg Commerce, Inc….
Survey of 1,000 employees in the US MUNICH, Germany–(BUSINESS WIRE)–#AI—63 percent of employees in the…
Rightpoint leverages deep understanding of customer, employee, and product experiences to help transform how people,…
David Daeschler, currently OneRail’s Chief Technology Officer, promoted to newly created role of Executive Vice…
— VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet…
Rentschler Biopharma to conduct adeno-associated virus (AAV) process development work for manufacturing scale-up at their…
SAN ANTONIO–(BUSINESS WIRE)–NuStar Energy L.P. (NYSE: NS) today announced that its 2022 Schedule K-3, reflecting…
Neumifil is being developed for the prevention and treatment of virus induced exacerbations in patients…
TOKYO, Jun 1, 2023 – (JCN Newswire) – TOYOTA GAZOO Racing will be part of…
Generative AI Changes Everything REDWOOD CITY, Calif.–(BUSINESS WIRE)–C3.ai, Inc. (NYSE: AI), the Enterprise AI application…
SAN FRANCISCO–(BUSINESS WIRE)–SoFi Technologies, Inc. (NASDAQ: SOFI), the digital personal finance company, today announced plans…
Expansion project will increase working storage capacity by more than 6 Bcf HOUSTON–(BUSINESS WIRE)–Kinder Morgan,…
Kontron’s ACE Flight™ 4783 dual modem MODMAN together with ThinKom’s Ka2517 antenna give customers access…
The Infinigate Group, following another year of double-digit growth, has appointed Simon England, former CEO…
ZURICH, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in…
ZURICH, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in…
The Phase II clinical trial investigates Philogen’s immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™…
The Phase II clinical trial investigates Philogen’s immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™…
With regulatory approvals now in place, Chemours and BWT officially launch THE Mobility F.C. Membranes…